160 related articles for article (PubMed ID: 37301776)
21. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
[TBL] [Abstract][Full Text] [Related]
22. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
Wang X; Huang Y; Li S; Zhang H
Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
[TBL] [Abstract][Full Text] [Related]
23. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
Wang LJ; Lv P; Lou Y
Front Oncol; 2022; 12():862723. PubMed ID: 35574375
[TBL] [Abstract][Full Text] [Related]
24. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
25. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
26. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
[TBL] [Abstract][Full Text] [Related]
28. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
29. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
Huang Q; Li J; Mo L; Zhao Y
World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
[TBL] [Abstract][Full Text] [Related]
30. Molecular prognostic of nine parthanatos death-related genes in glioma, particularly in COL8A1 identification.
Fan S; Li H; Liu K
J Neurochem; 2024 Mar; 168(3):205-223. PubMed ID: 38225203
[TBL] [Abstract][Full Text] [Related]
31. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix-based gene signature for predicting prognosis in colon cancer and immune microenvironment.
Chai R; Su Z; Zhao Y; Liang W
Transl Cancer Res; 2023 Feb; 12(2):321-339. PubMed ID: 36915600
[TBL] [Abstract][Full Text] [Related]
33. Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.
Wang L; Liu Y; Yu Z; Gong J; Deng Z; Ren N; Zhong Z; Cai H; Tang Z; Cheng H; Chen S; He Z
J Transl Med; 2021 May; 19(1):213. PubMed ID: 34001135
[TBL] [Abstract][Full Text] [Related]
34. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
[No Abstract] [Full Text] [Related]
35. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
36. Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients.
Yu H; Wang M; Wang X; Jiang X
FEBS Open Bio; 2023 Feb; 13(2):307-322. PubMed ID: 36560848
[TBL] [Abstract][Full Text] [Related]
37. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
39. A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
Luo C; Wang S; Shan W; Liao W; Zhang S; Wang Y; Xin Q; Yang T; Hu S; Xie W; Xu N; Zhang Y
Front Immunol; 2022; 13():909189. PubMed ID: 35769464
[TBL] [Abstract][Full Text] [Related]
40. Construction of a novel microRNA-based signature for predicting the prognosis of glioma.
Liu G; Rong X; Lin X; Wang H; He L; Peng Y
Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
